Bayer, CSL Behring Recall Antihemophilic Factor Products Formulated with Sucrose
Tue, 23 Aug 2016 00:00:00 -0400
The potency of the active ingredient in several lots of Kogenate FS and Helixate FS antihemophilic factor when analyzed during stability testing has been declining faster than expected, prompting Bayer HealthCare LLC and CSL Behring LLC to extend recalls the companies said they initially communicated a month ago, according to notices posted on Monday by FDA.
New Federal Law Aims to Stem Opioid Abuse
Mon, 15 Aug 2016 00:00:00 -0400
The Comprehensive Addiction and Recovery Act of 2016, signed into law July 22, takes a broad approach to tackling the national crisis of opioid abuse and mandates input from pharmacists about solving the problem.
Comprehensive Care Is Key in HIV Management, Pharmacists Say
Caring for HIV-infected patients involves more than overseeing antiretroviral therapy, say pharmacists on multidisciplinary primary care teams at HIV clinics.
Amikacin Injection Vials Recalled by Teva
Wed, 03 Aug 2016 00:00:00 -0400
Teva Pharmaceuticals on Tuesday announced a recall of seven lots of amikacin sulfate injection because the vials might contain glass particles.
Medicare Delays Mandate on Claims for Unused Part of Drug Doses
Tue, 26 Jul 2016 00:00:00 -0400
Hospital clinics and outpatient departments that bill Medicare for unused portions of certain medications recently gained six additional months to meet newly mandated documentation and billing requirements.